Swisse is seeking to pioneer Australia’s nootropics consumption with the launch of three new SKUs designed for focus, memory, ...

LAS VEGAS, NV / ACCESSWIRE / October 9, 2024 / (OTC PINK:NICH) is proud to announce the official launch of its newest vertical, InTheZone Labs, in partnership with a leading American-based bioceutical ...

Context: Many children with attention-deficit/hyperactivity disorder (ADHD) continue to exhibit symptoms of the disorder into adolescence and adulthood. Although ADHD ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...